Clinical Trial Update: Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC [Phase 2]

View source ↗

Summary

This Phase 2 trial assesses induction gemcitabine and carboplatin followed by paclitaxel and carboplatin with radiation therapy in non-small cell lung cancer. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-05-23